Swiss National Bank Portfolio holdings
The Swiss National Bank (SNB), founded in 1907 and headquartered in Zurich with an office in Bern, is Switzerland’s central bank, responsible for conducting monetary policy, issuing the Swiss franc, and ensuring price stability, while uniquely managing a massive investment portfolio. Unlike most central banks, the SNB is a joint-stock company with shares traded on the SIX Swiss Exchange, owned roughly 55% by public entities like cantons and 45% by private investors, yet it operates independently under federal oversight. It holds over $800 billion in foreign currency reserves as of late 2024—invested in global equities, bonds, and gold—to manage the franc’s value, famously intervening in markets to prevent excessive appreciation, as seen with the 2015 abandonment of the euro peg. Led by Chairman Thomas Jordan until his planned exit in September 2024, the SNB balances its dual role as a monetary authority and a significant global investor, influencing both Swiss and international financial stability.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$411M |
| 2 |
Microsoft
MSFT
|
+$309M |
| 3 |
ExxonMobil
XOM
|
+$258M |
| 4 |
Johnson & Johnson
JNJ
|
+$221M |
| 5 |
GE Aerospace
GE
|
+$217M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
BRCM
BROADCOM CORP CL-A
BRCM
|
+$58.7M |
| 2 |
PCP
PRECISION CASTPARTS CORP
PCP
|
+$57.9M |
| 3 |
CB
CHUBB CORPORATION
CB
|
+$54.7M |
| 4 |
Stellantis
STLA
|
+$25.2M |
| 5 |
GMCR
KEURIG GREEN MTN INC
GMCR
|
+$20M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.83% |
| 2 | Healthcare | 14.67% |
| 3 | Consumer Discretionary | 10.51% |
| 4 | Consumer Staples | 10.31% |
| 5 | Industrials | 10.29% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ENLC
2026
DELISTED
ENLINK MIDSTREAM, LLC
ENLC
| $825K | ﹤0.01% |
76,123
+15,000
| +25% | +$161K |
|
2027
Enterprise Financial Services Corp
EFSC
$2.4B
| $823K | ﹤0.01% |
31,464
+5,400
| +21% | +$147K |
|
2028
Alamo Group
ALG
$1.99B
| $822K | ﹤0.01% |
15,300
+3,000
| +24% | +$159K |
|
2029
Archrock
AROC
$5.85B
| $820K | ﹤0.01% |
106,300
+20,000
| +23% | +$111K |
|
|
IQNT
2030
DELISTED
Inteliquent, Inc.
IQNT
| $819K | ﹤0.01% |
52,900
+10,200
| +24% | +$169K |
|
2031
Cass Information Systems
CASS
$750M
| $816K | ﹤0.01% |
21,252
+3,696
| +21% | +$141K |
|
2032
OneSpan
OSPN
$624M
| $816K | ﹤0.01% |
54,700
+9,100
| +20% | +$135K |
|
2033
Theravance Biopharma
TBPH
$878M
| $816K | ﹤0.01% |
45,042
+12,400
| +38% | +$203K |
|
|
DHIL
2034
DELISTED
Diamond Hill
DHIL
| $813K | ﹤0.01% |
4,754
+900
| +23% | +$157K |
|
|
NWLI
2035
DELISTED
National Western Life Group, Inc. Class A
NWLI
| $811K | ﹤0.01% |
3,649
+1,149
| +46% | +$254K |
|
|
BNFT
2036
DELISTED
Benefitfocus, Inc.
BNFT
| $811K | ﹤0.01% |
25,200
+4,800
| +24% | +$143K |
|
2037
Heritage Financial
HFWA
$1.23B
| $808K | ﹤0.01% |
47,668
+9,100
| +24% | +$160K |
|
2038
QuidelOrtho
QDEL
$1.03B
| $805K | ﹤0.01% |
48,300
+8,600
| +22% | +$144K |
|
|
GIMO
2039
DELISTED
Gigamon Inc.
GIMO
| $802K | ﹤0.01% |
26,800
+5,100
| +24% | +$133K |
|
2040
Matrix Service
MTRX
$328M
| $800K | ﹤0.01% |
46,700
+8,100
| +21% | +$146K |
|
2041
StoneX
SNEX
$8.05B
| $800K | ﹤0.01% |
155,925
+23,794
| +18% | +$128K |
|
2042
Insteel Industries
IIIN
$634M
| $795K | ﹤0.01% |
27,000
+5,300
| +24% | +$132K |
|
|
FTD
2043
DELISTED
FTD Companies, Inc. Common Stock
FTD
| $795K | ﹤0.01% |
31,320
+5,600
| +22% | +$136K |
|
|
KERX
2044
DELISTED
Keryx Biopharmaceuticals Inc
KERX
| $795K | ﹤0.01% |
176,100
+31,900
| +22% | +$127K |
|
2045
ePlus
PLUS
$2.31B
| $794K | ﹤0.01% |
40,856
+8,000
| +24% | +$165K |
|
|
PDLI
2046
DELISTED
PDL BioPharma, Inc.
PDLI
| $793K | ﹤0.01% |
247,200
+51,100
| +26% | +$159K |
|
2047
Ennis
EBF
$559M
| $791K | ﹤0.01% |
41,900
+7,800
| +23% | +$152K |
|
|
EXTN
2048
DELISTED
Exterran Corporation
EXTN
| $791K | ﹤0.01% |
53,050
+9,900
| +23% | +$150K |
|
2049
Moelis & Co
MC
$5.21B
| $790K | ﹤0.01% |
29,000
+5,500
| +23% | +$141K |
|
|
ADAM
2050
Adamas Trust
ADAM
$907M
| $790K | ﹤0.01% |
43,230
+8,300
| +24% | +$156K |
|
Similar funds
Swiss National Bank's Q1 2016 Portfolio in Review
As of Q1 2016, Swiss National Bank held 2,649 positions worth $54.5B, up 32% from $41.3B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Swiss National Bank deployed $13.6B of net new capital in Q1 2016, opening 6 new positions and adding to 2,585 existing holdings. Its largest new stake was Ferrari: 823,472 shares worth $32.9M.
By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 15% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was Stellantis, an estimated $25.2M trimmed.
- Swiss National Bank's largest Q1 2016 buy was Ferrari: 823,472 shares worth $32.9M.
- Swiss National Bank added most to Apple in Q1 2016, an estimated $411M increase.
- Swiss National Bank's biggest Q1 2016 reduction was Stellantis, cutting an estimated $25.2M.
- Swiss National Bank fully exited BROADCOM CORP CL-A in Q1 2016, selling an estimated $58.7M.
- Swiss National Bank's ten largest holdings make up 15% of its $54.5B portfolio in Q1 2016.
- Swiss National Bank opened 6 new positions and closed 38 in Q1 2016.
- Swiss National Bank's portfolio value rose 32% quarter-over-quarter to $54.5B.
Based on Swiss National Bank's 13F filing for Q1 2016, filed 4 May 2016.